Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT)

Inclusion Criteria

• •All adults admitted to the MICU at Boston Medical Center (BMC) during the study period who develop AF with RVR whose treating clinicians decides intravenous (IV) rate control agent is necessary to manage AF with RVR
• •Patients readmitted to the MICU during the study period with recurrence of AF with RVR after conversion to sinus rhythm or prior rate control